Triple antiviral drug shows early promise in Covid-19 trial | Malay Mail

📆 5/9/2020 5:16 AM
📰 malaymail

⏱ Reading Time:
20 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 86%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

LONDON, May 9 — A triple drug combination of antiviral medicines helped relieve symptoms in patients with mild to moderate Covid-19 infection and swiftly reduced the amount of virus in their bodies, according to results of a small trial in Hong Kong. The trial, which involved 127 patients,...

File photo of a woman holding a small bottle labbelled with a 'Vaccine Covid-19' sticker and a medical syringe in this illustration taken April 10, 2020. — Reuters pic

The findings, published in the Lancet medical journal, showed that on average, people who got the triple drug reached the point of no detectable virus five days earlier than those in the control group — at 7 days versus 12 days. In the trial, all patients received standard hospital care as needed, including ventilation support, dialysis support, antibiotics and corticosteroids.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Triple antiviral drug combination shows early promise in Covid-19 trialResearchers say effect now needs to be tested in larger numbers and in severely infected patients. FMTNews
Source: fmtoday - 🏆 5. / 72 Read more »